A Phase I/II Clinical Trial of Intramyocardial Injection of HucMSCs for the Treatment of Chronic Heart Failure

Clinical trial NCT07265349 · RECRUITING

Trial details

NCT number: NCT07265349
Sponsor: Tasly Pharmaceutical Group Co., Ltd
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Coronary Artery Bypass Grafting (CABG)Chronic Heart Failure Chronic Ischemic Cardiomyopathy

Start date: 2025-12-26
Primary completion: 2026-12-31
Enrollment: 51

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.